Thermo Fisher Scientific is opening a new facility in Hangzhou, China, as part of its global effort to help compani...
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, lau...
Medeologix, a Taiwan-based medtech CDMO company, has announced its successful acquisition of three premier medical devic...
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organisation (CRDMO), has launched its...
WuXi Vaccines, a leading global Contract Development and Manufacturing Organisation (CDMO), has entered into an agreemen...
Founded in 2015 by Koji Tanabe, a graduate of Professor Shinya Yamanaka's laboratory at Kyoto Univer...
Terumo Pharmaceutical Solutions (TPS), a leading manufacturer of injection, primary container, and infusion therapy devi...
South Korea-based startup Lotte Biologics has signed a memorandum of understanding (MoU) with Huons Global for clinical ...
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has successfully...
Samsung Biologics, South Korea-based contract development and manufacturing organization (CDMO), has announced that its ...
Fujifilm Corporation has announced that it will establish the company’s first Japanese Bio-CDMO (contract developm...
Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cel...
South Korea-based Samsung Biologics, a world-leading contract development and manufacturing organization (CDMO), is laun...
Singapore-based startup Biosyngen has signed to set up a cell therapy GMP facility which will serve as a base to develop...
WuXi STA, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the ope...
Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals has partnered with TaiRx, Inc., a Tai...
Great Bay Bio (GBB), Hong Kong-based startup, has announced the completion of its $15 million Pre-series B funding ...
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, lau...
AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr Gle...
China's WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), has anno...
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of China-based WuXi AppTec, has announced a licensing agre...
BioDuro-Sundia, an industry-leading drug discovery, development and commercial service contract research development and...
The COVID-19 pandemic highlighted the successful development and utilisation of mRNA vaccines. This has encouraged bioph...
WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), has announced a ...
Samsung Biologics, a South Korea-based contract development and manufacturing organization (CDMO), has signed a land pur...
